Analytical specificity of commercially available methods for serum phenytoin determination.
暂无分享,去创建一个
[1] D. Olive,et al. Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma. , 1982, Clinical chemistry.
[2] M. Jolley. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. , 1981, Journal of analytical toxicology.
[3] G. Matzke,et al. Elevated Serum Phenytoin Concentrations in a Uremic Patient When Measured by Enzyme-Multiplied Immunoassay , 1981, Drug intelligence & clinical pharmacy.
[4] D. S. Kabakoff,et al. Metabolite interference in homogeneous enzyme immunoassay of phenytoin. , 1981, Clinical chemistry.
[5] P. Finley,et al. Rate-nephelometric inhibition immunoassay of phenytoin and phenobarbital. , 1981, Clinical chemistry.
[6] R. Sawchuk,et al. Liquid-chromatographic method for simultaneous determination of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in plasma and urine. , 1980, Clinical chemistry.
[7] J. Rasmussen,et al. Renal disease may increase apparent phenytoin in serum as measured by enzyme-multiplied immunoassay. , 1980, Clinical chemistry.
[8] D. M. McDonald,et al. Renal disease may increase apparent phenytoin in serum as measured by enzyme-multiplied immunoassay. , 1980, Clinical chemistry.
[9] D. Daly,et al. Inheritance of phenytoin hypometabolism: A kinetic study of one family , 1980, Clinical pharmacology and therapeutics.
[10] J. Hull. The Effect of Disease States on Drug Pharmacokinetics , 1977 .
[11] T. Ludden,et al. Individualization of phenytoin dosage regimens , 1977, Clinical pharmacology and therapeutics.
[12] H. Vainio. LINKAGE OF MICROSOMAL DRUG OXIDATION AND GLUCURONIDATION , 1976 .
[13] J. Penry,et al. Usefulness of blood levels of antiepileptic drugs. , 1974, Archives of neurology.
[14] H. Booker,et al. Serum Concentrations of Free Diphenylhydantoin and their Relationship To Clinical Intoxication , 1973, Epilepsia.
[15] E. F. Ullman,et al. "Homogeneous" enzyme immunoassay. A new immunochemical technique. , 1972, Biochemical and biophysical research communications.
[16] F. Sjöqvist,et al. Abnormal pharmacokinetics of phenytoin in a patient with uraemia. , 1970, Lancet.
[17] J. Haynes,et al. Some causes of ineffectiveness of diphenylhydantoin. , 1966, Archives of neurology.